Absci Corporation is a generative artificial intelligence (AI) drug creation company. Co. combines AI with scalable wet lab technologies to create biologics for patients. It has built an Integrated Drug Creation platform to identify novel drug targets, discover biotherapeutic candidates, and generate the cell lines to manufacture them in a single process. Co. uses its platform to predict, identify, design, construct, screen, select and scale production of biologic drug candidates for its partners, and learn from the data it generates. Its SoluPro technology is a multiplex synthetic biology approach that overcomes the limitations of highest-throughput automation labs. We show 14 historical shares outstanding datapoints in our ABSI shares outstanding history coverage, used to compute ABSI market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ABSI market cap history over the course of time is important for investors
interested in comparing ABSI's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ABSI versus a peer is one thing; comparing
ABSI market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ABSI can fluctuate over the course of history.
With this page we aim to empower investors researching ABSI by allowing them to research the ABSI market cap history. |
Free ABSI Email Alerts:
Video: The Importance of Market Cap
